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Background: Lung cancer is the leading cause of cancer-related morbidity and mortality all over the world. Surgery
resection, radiotherapy, chemotherapy, immunotherapy and combined treatments have been discovered and well
established for treatments. However, low survival rate of five years after clinical treatments mainly due to recurrence
of stress-resistant cancer cells calls for better understanding and new ideas. Our project aimed to understand the
forming process of stress resistant lung cancer cells after radiotherapy.
Methods: Two classic non-small cell lung cancer (NSCLC) cell lines A549 and H1299 initially were radiated with a
137Cs gamma-ray source with doses ranging from 0 to 12 Gy to generate radiation-resistant cancer cells. 8 Gy of
radiation was regard as a standard dosage since it provides effective killing as well as good amount of survivals.
The expression levels of autophagy-related proteins including Beclin-1, LC3-II and p62 were studied and measured
by both western blot and quantitative real-time polymerase chain reaction (real-time RT-PCR).
Results: Increased Beclin-1, LC3-II and decreased p62 have been observed in radiation-resistant cells indicating elevated
autophagy level. Decreased miR-191 in radiation-resistant cells performed by Taqman qRT-PCR also has been seen. Two
binding sites between Beclin-1 and miR-191 suggest potential association between.
Conclusions: It is reasonable to speculate that inhibition of miR-191 expression in lung cancer cells would contribute to
the establishment of radiation-resistant cells via mediating cellular autophagy. Therefore, miR-191 is a potential target for
therapy in treating radiation-resistant lung cancer.
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Lung cancer is the leading cause of cancer-related mortality
and morbidity and it is one of the predominant life-
threatening conditions among cancers. For 50 years both
the morbidity and mortality rates from many countries
have increased significantly [1]. However, the exact cause
underlying lung cancer is still unrevealed. Improvements
in long term survival rate have been achieved by early
diagnosis and combinations of chemo/radiotherapy and
surgery. However, the recurrence rate is still high and five
years survival for NSCLC patients remains as low as 15%
[2]. One main factor could be the resistant cancer cells
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unless otherwise stated.For now, there is no medicine shown to be signifi-
cantly effective and consistent to treat lung cancer.
When feasible, surgical resection is still the single most
effective and successful option especially for early-stage
patients [3-5]. There are two main types of lung cancer,
small cell lung cancer (SCLC) and non-small cell lung
cancer (NSCLC). NSCLC accounts for around 84% of all
the cases. NSCLC patients are more likely to be cured
with surgery resection if discovered at an early stage [6].
Radiotherapy, chemotherapy, immunotherapy and com-
bined treatments would be chosen based on tumour
stage and histologic type based on accurate diagnosis.
Radiotherapy is the most important localised treatment
across every clinical phase of NSCLC patients. However,
the records of the past two decades shown that only
5-10% of patients survived 5 years after clinical therapyral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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relation between recurrence and distant metastasis [8],
therefore recurrence is the main cause responsible for
failed treatment and the occurrence of metastasis of
NSCLC. The recurrence is frequently associated with
stress-resistant cancer cells after therapies [9]. A study
focusing on 598 stage I NSCLC patients who underwent
surgery resection illustrated around 27% of overall recur-
rence incidences [10]. Our project aimed to understand
the forming process of stress-resistant lung cancer
cells after radiotherapy. In our experiment, two classic
NSCLC cell lines A549 and H1299 were chosen. Survived
cells with three week’s radiation were used as the cell
model after radiotherapy for further experiments.
Autophagy is a catabolic process to breakdown and re-
cycles dysfunctional cellular components such as organ-
elles and proteins by isolating these selected components
inside a double membrane-bound vesicle. This function is
used as a survival mechanism by starving cells [11,12].
When it comes to cancer cells, it could maintain the me-
tabolism of mitochondrial, improve cell proliferation
and increase stress tolerance. All of these effects together
would eventually contribute to the level of malignance.
Additionally, it may interfere with chemotherapy and
radiation-induced apoptosis through removal of damaged
organelles [13]. These evidences suggest the role autoph-
agy might play in tumor development [14]. It hints that
inhibition of autophagy activity is the effective way to sup-
press the development of cancer. MicroRNA is a single-
stranded small sequence of non-coding RNA molecule
with length of 20–24 nucleotides which accounts for
post-transcriptional regulation of gene expression [15,16].
MicroRNA could silence gene expression by specific bind-
ing through base pairing with complementary mRNA se-
quence followed by degradation of the target mRNA [17].
Therefore it plays a crucial role in regulation of gene ex-
pression, cell cycling and developmental timing [18]. It is
estimated that miRNAs modulates over one-third of hu-
man genes and various biological pathways [19]. Some
studies illustrated degradation of miRNA might con-
tribute to the developments of various diseases including
cancer [20]. The link established between autophagy and
miRNA is the possible regulation function of miRNA
upon autophagy [20]. Dysfunctional miRNAs are fre-
quently found in malignancies where they function as
either oncogenes or tumor suppressors [21]. MiRNA has
been suggested to prevent the development of lung cancer
by inhibiting some specific function proteins involved in
autophagy pathway. So far some researches have pointed
out the potential correlation between dysfunctions of
miRNA-186, 143 [22], 17–92 cluster [23,24] and the pro-
gress of lung cancer. In this report, we also found the re-
duced expression level of miRNA-191 in two types of
NSCLC based on miRNA microarray techniques. However,the link between miRNA-191 and autophagy has not been
reported in other studies. Taken together, we propose that
the inhibition mechanism to lung cancer by miRNA-191 is
conducted by targeting specific proteins of autophagy path-
way, which eventually inhibit the growth and proliferation
of lung cancer cells. The phenomenon could be helpful for
therapy of lung cancer in the future.
Results and discussion
Various studies have illustrated the significant role autoph-
agy plays during the progress of tumor cells, including
representing cell survival mechanism as well as tumor
suppression. In our experiments, autophagy related pro-
teins such as Beclin-1 and LC3-II were found to be upregu-
lated in two NSCLC radiation-resistant cell lines, indicating
enhanced level of autophagy in radiation-resistant cancer.
Increasing amount of studies were performed to under-
stand tumor biology from microRNA profile perspective.
Establishment of radiation-resistant cancer cells
Two non-small cell lung cancer cell lines A549 and
H1299 were chosen for this project. In order to investigate
the role microRNA might play in the forming process of
radiation-resistant cancer cells during radiotherapy, nor-
mal A549 and H1299 cells were treated with 137Cs
gamma-ray source with dosages ranging from 0, 2, 4, 8 to
12 Gy. ODs measured (Figure 1A and B) on different days
show an increasing trend, which illustrated gradual
growth of surviving cells after radiation. The results
showed the killing effect was radiation dosage-dependent
on both cell lines. 8 Gy radiation dosage was selected as a
standard since then because it kills fairly enough cells and
also provides good amount of survived cells for further ex-
periments. Figure 1C shows the images generated from
fluorescent dye DAPI staining and it clearly demonstrate
much more living cells survived after radiation treatment
comparing with the cells on 21 d. Taken together, we can
conclude that radiation treatment effectively kills both
A549 and H1299 cells. As expected, there was a small
fraction of cells radiation, which closely mimiced the clin-
ical radiotherapy-resistant lung cancer cases. This popula-
tion of radiation-resistant cells might eventually lead to
the recurrence of cancer. The radiation-resistant models
established by using the treatment discussed above would
be utilized for further experiments.
Autophagy-associated protein profile
The second part of this project is to study expression
profiles of autophagy associated proteins in radiation-
resistant cells. Beclin-1 is an autophagy marker protein
in human [25,26] which is also involved in cell death,
neurodegeneration, tumorigenesis and development [27].
Overexpressed Beclin-1 has been observed in gastric
cancer cells from previous study [28]. A type of Beclin-1
Figure 1 The radiation survived cells have the growth capacity for a long time. (A) OD values of A549 cells. (B) OD values of H1299 cells.
(C) Normal A549 and H1299 cells and the cells treatment with 8 Gy radiation after 3 weeks were stained by DAPI (blue) and images were
acquired under fluorescence microscopy.
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tumor growth in a NSCLC tumor xenograft model [29].
LC3-II is another autophagic marker that is usually
down-regulated in human lung cancers [30]. p62 is a
signaling adaptor, which accounts for Ras-induced sur-
vival and transformation and is also found to be overex-
pressed in tumor cells [31]. The increased expression
levels of autophagy associated Beclin-1 and LC3-II and
reduced p62 level have been observed in radiation-
resistant group in comparison to control group in both
lung cell lines (Figure 2A-D). In order to analyze pre-
cisely the differences of expression levels between ra-
diation resistant and untreated cancer cells, relativemRNA levels of Beclin-1, LC3-II and p62 were also
measured by qRT-PCR. PCR results shown in Figure 2C
and D also confirmed elevated level of both Beclin-1
and LC3-II and decreased p62. These changes of au-
tophagy associated protein expression levels indicated
enhanced level of autophagy in radiation resistant can-
cer cells. One study demonstrated that knockdown of
Beclin-1 and another autophagy related gene ATG5 lead
to higher sensitivity to radiation, suggesting cytoprotec-
tive function of induced autophagy [32]. This might
also explain why enhanced level of autophagy has been
observed in radiation-resistant cancer cells during our
experiment.
Figure 2 (See legend on next page.)
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Figure 2 Autophagy upregulated in radiation resistant A549 and H1299 compared in non-radiation resistant A549 and H1299.
(A, C) Expression status of certain autophagic marker proteins Beclin-1, LC3-II, p62 and GAPDH (loading control) in non-treatment A549 and
radiation treatment A549 cells. (B, D) Expression status of certain autophagic marker proteins Beclin-1, LC3-II, p62 and GAPDH (loading control)
in non-treatment H1299 and radiation treatment H1299 cells. (E) Relative Beclin-1, LC3-II and p62 mRNA expression levels in normal A549 and
radiation resistant A549 cells, bars represent mean ± S.E. (*p <0.05 vs control, n = 3). (F) Relative Beclin-1, LC3-II and p62 mRNA expression
levels in normal H1299 and radiation resistant H1299 cells, bars represent mean ± S.E. (*p <0.05 vs control, n = 3).
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Up and down-regulated miRNAs were listed based on
high-throughput microarray assay in Figure 3A. Among
all the miRNAs analyzed, miR-7, miR-140, miR-150,
miR-107, miR-155, miR-191 were found to be significantly
up or down-regulated in radiation-resistant compared to
non-treatment cells (Figure 3B and C). Dysregulated miR-
191 has been discovered in various types of human tu-
mors such as breast, prostate [33] and colorectal cancer
[34]. miR-191 is a highly conversed molecule and has been
found dysregulated in more than 20 cancer types [35].
miR-191 is highly overexpressed in lung cancer patients
and is suggested to be an oncogenic miRNA [33]. It is also
an excellent candidate for disease diagnosis as it is non-
invasive and widely spread in human serum or saliva [36].
Thus, miR-191 represented the most significant difference
and therefore drew an attention for further analysis in our
study. The comparisons of relative miR-191 levels by Taq-
man qRT-PCR between radiation-resistant and non-
radiation treated cells were conducted and results are
shown in Figure 3B and C. Results were normalized to
snU6 expression level and represented as mean ± S.E.
from three independent replicates. As shown in Figure 3B
and C, there is significant reduction of miR-191 expres-
sion level in both radiation resistant A549 and H1299
cells. In order to whether miR-191 levels would influ-
ence cell viability, radiation-resistant cancer cells were in-
fected with Lenti-virus-miR-191 to overexpress miR-191.
Figure 3D shows that with miR-191 overexpression and
radiation-resistant treatment (8 Gy) for 3 weeks in A549
and H1299 cells, viability of residual cells was decreased
to 40% of the negative controls without miR-191 overex-
pression. These results indicated that miR-191 overexpres-
sion plays a key role in radiation-resistance in A549 and
H1299 lung cancer cells.
Association between miR-191 and autophagic marker
We next investigated if there is any link between miR-
191 and autophagic maker proteins. Potential binding
sites between miR-191 seed sequence and Beclin-1 se-
quence were predicted by comparing base pairs of each.
Two complementary binding sites were detected which
indicate potential binding affinity between Beclin-1 and
miR-191. Those two binding sites were then knockedout for further infection treatment. Radiation-resistant
cells were infected with Lenti-virus-Beclin-1wt and mut
(two mutation sites of Beclin-1) respectively (Figure 4A).
Figure 4B and C showed there were relatively lower ex-
pression levels of miR-191 in Beclin-1 mut infected cells,
suggesting decreased binding affinity between miR-191
and Beclin-1 as a result of removal of binding sites. There-
fore our result indicated potential pathological association
between miR-191 and autophagic marker protein Beclin-1
in lung cancer cells.MiR-191 modulated Beclin-1 expression
Recent study has revealed there are more radiation resistant
cancer cells appearring along with hypoxia-mediated au-
tophagy, suggesting the existence of autophagy-mediated
stress resistant mechanism for cancer cells [37]. It is rea-
sonable to speculate that inhibition of miR-191 expression
in lung cancer cells would contribute to the establishment
of radiation-resistant cells via mediating cellular autophagy.
Vice versa, elevated miR-191 might also interfere with the
forming of stress resistant cancer cells. The next step is to
study whether autophagic activity would be affected if ex-
pression level of miR-191 increases in radiation-resistant
lung cancer cells. The data demonstrated reduced amount
of Beclin-1 and Lc3-II and increased p62 level in cells over-
expressing miR-191 via western blot (Figure 5A and B) as
well as qRT-PCR (Figure 5C and D), which suggested re-
duced autophagy level with overexpression of miR-191.
These data further verified that miR-191 target autophagy
associated Beclin-1 via two base pairing sites to interfere
with autophagy. Therefore, miR-191 is a biomarker for can-
cer diagnosis, prognosis, and moreover serves as a potential
target for the prevention of tumor recurrence after
radiotherapy.
To summarize our study, we performed high-throughput
microarray assay and found significantly decreased level of
miR-191 in radiation-resistant cells than normal non-
treatment cancer cells. Base-paired sequences between
miR-191 and Beclin-1 reveal certain correlation be-
tween them. Taken together we speculate that miR-191
level reduces in survived radiation-resistant lung can-
cer cells, leading to increased autophagy level. Our
study provides evidence supporting the role of miR-191 as
Figure 3 miR-191 was functionally involved in the radiation resistance to A549 and H1299 cells. (A) Micro-RNA profiles of radiation
resistant and non radiation resistant A549 and H1299 cells were shown. Supervised hierarchical clustering of cell lines based on their differential miRNAs
expression with ΔLMR > 2 between the two groups were exhibited. Each column represents a cell line and each row a probe set. (B-C) Relative miRNAs
expression in A549 and H1299 cells in (A). (D) Downregulation of miR-191 expression in radiation resistant A549 compared to non-radiation resistant
A549 cells. Results were normalized to snU6 expression level and represented as mean ± S.E. from three independent replicates. (*p <0.05 vs
control, n = 3). (E) Downregulation of miR-191 expression in radiation resistant H1299 compared to non-radiation resistant H1299 cells.
Results were normalized to snU6 expression level and represented as mean ± S.E. from three independent replicates. (*p <0.05 vs control, n = 3). (F) Cell
viability after infected with Lenti-virus-miR-191 for 48 h.
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Figure 4 Beclin-1 was a direct target of miR-191. (A) Schematic representation of the 39- UTR of human Beclin-1 transcript. Predicted miR-191
binding site was depicted. The numbers (+121–140) represented the nucleotides that were predicted to base pair with the miR-191 seed
sequence. (B) The expression of miR-191 in radiation-resistant A549 cells with or without Beclin-1 mutation (*p <0.05 vs control, n = 3).
(C) The expression of miR-191 in radiation-resistant H1299 cells with or without Beclin-1 mutation (*p <0.05 vs control, n = 3).
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especially in radiation-resistant cases in the future.
Methods
Cell culturing and proliferation
Cell culturing and established models of radiation-resistant
cell lines A549 and H1299 cells were harvested by exposingto trypsin. Cell suspensions were irradiated using a 137Cs
gamma-ray source with doses ranging from 0 to 12 Gy and
plated in 6 well plates, 500 cells per well. Cultures were in-
cubated at 37°C in 5% CO2. Optical density of each group
with different dosages of radiation was detected at 7 times
by using CCK-8 (Day 2, 4, 7, 10, 14, 18 and 21). The 8 Gy
was chosen as a standard radiation dosage for the next test.
Figure 5 miR-191 modulated Beclin-1 expression in radiation resistant A549 and H1299 cells. (A) Expression status of certain autophagic
marker proteins Beclin-1, LC3-II, p62 and GAPDH (loading control) in miR-191-overexpressed A549 cells. (B) Expression status of certain autophagic
marker proteins Beclin-1, LC3-II, p62 and GAPDH (loading control) in miR-191-overexpressed H1299 cells. (C) Relative Beclin-1, LC3-II and p62
mRNA expression levels in miR-191 mutant A549 cells. bars represent mean ± S.E. (*p <0.05 vs control, n = 3). (D) Relative Beclin-1, LC3-II and p62
mRNA expression levels in miR-191 mutant H1299 cells. bars represent mean ± S.E. (*p <0.05 vs control, n = 3). (E) Relative Beclin-1, LC3-II and
p62 mRNA expression levels in miR-191 overexpressed A549 cells, bars represent mean ± S.E. (*p <0.05 vs control, n = 3). (F) Relative Beclin-1,
LC3-II and p62 mRNA expression levels were quantified by qRT-PCR analysis in miR-191 overexpressed H1299 cells, bars represent mean ± S.E.
(*p <0.05 vs control, n = 3).
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after 3 weeks were stained with DAPI (blue) for cell viabil-
ity. Images were acquired under fluorescent microscopy.
CCK-8 staining
CCK-8 staining was used to detect cell growth conditions.
100 μl of cell suspension (5000 cells/well) obtained from 2,
4, 7, 10, 14, 18 and 21 days after radiation treatment were
dispensed into a 96-well plate. This plate was pre-incubated
for 24 hours in a humidified incubator (e.g., at 37°C, 5%
CO2). 10 μl of various concentrations of substances were
added to the plate to be tested. The plate was then incu-
bated for an appropriate length of time (e.g. 6, 12, 24 or
48 hours) in the incubator. 10 μl of CCK-8 solution was
added to each well of the plate. Incubate the plate for 1–4
hours in the incubator. Measurement of the absorbance at
450 nm was performed by a microplate reader.
Western blot
Expression levels of Beclin-1, LC3-II and p62 were
determined by Western blot. Cells were harvested and
lysed with lysis buffer (RIPA, Abcam). 20 μl 2 × sample
loading buffer was added into each sample (0.125 M of
5 M Tris–HCl, amresco; 20% glycerol, usb; 4% of 10% so-
dium dodecyl sulfate, amresco; 1% β-mercaptoethanol,
amresco; 0.2% of 0.05% (w/v) bromophenol blue, sigma).
GAPDH was used as a loading control. 10% running gel
(25% of 40% acrylamide stock, Beyotime; 0.375 M of 1.5 M
Tris–HCl, pH 8.8; 1% of 10% sodium dodecyl sulfate; 1%
of 10% ammonium persulfate; 0.1% tetramethylethylene-
diamine) was utilized for samples that have been boiled for
5 minutes. The gel was transferred to a same size mem-
brane (Nitrocellulose transfer membrane, Protian) within
transfer buffer (25 mM Tris base, 192 mM glycine, 0.037%
sodium dodecyl sulfate, and 20% methanol) under 45 V for
40 min. The membrane was then incubated in primary
antibody (Beclin-1, GAPDH, Abcam) with a 1/1000 dilu-
tion in blocking buffer (50 mM Tris base; 100 mM NaCl;
0.02% Tween 20; and 3% BSA) overnight. The membrane
was rinsed by TTBS (0.1% Tween 20, 10 mM Tris base,
100 mM NaCl, pH 7.5) for three times before adding sec-
ondary antibody (Abcam) with 1/5000 dilution in blocking
buffer for 2 hours. Background noise was reduced by
careful wash. The results were visualized using ECL
kit (Abcam) and observed by GeneGnome mechine
(Syngene).
Real-time RT-PCR
mRNA of Beclin-1, LC3-II and p62 from cells were ex-
tracted by RNeasy Mini Kit (Qiagen). NanoDrop 8000
spectrophotometer (Thermo Scientific) was used to deter-
mine the quality and quantity of extracted RNA. 1000 ng
RNA was used for each reaction to produce cDNA using
high capacity cDNA reverse transcription kit (Appliedbiosystems) following manufacturer’s instructions. The re-
action was initiated at 25°C for 5 min followed by anneal-
ing at 50°C and subsequent elongation at 70°C. cDNA
products were then diluted by adding DNase and RNase
free water to 250 μl and frozen at −20°C for further gene
expression assay. 10 μl 1 × PCR master mix, 5 μl diluted
cDNA, 4 μl water and 1 μl probe were mixed together in
every reaction. Gene expression was measured with quan-
titative real-time RT-PCR system. Taqman real-time RT-
PCR was performed to specifically detect the relative levels
of miR-191 in radiation resistant and no radiation resistant
H1299 for higher sensitivity.
Micro-RNA profiles in radiation-resistant cells
Overexpressed and downexpressed miRNAs in both
A549 and H1299 were screened and selected based on
miRNA microarray assay. Taqman real-time qRT-PCR
was performed to detect the relative levels of miR-191
in radiation resistant and non-treatment cells. miR-191
was normalized against U6 spliceosomal RNA (U6
snRNA).
Cell viability evaluation with additional miR-191
Radiation resistant A549 and H1299 cells were infected
with Lenti-virus-miR-191 for 48 h. The cells with or with-
out treatment of Lenti-virus-miR-191 were subjected to
FACS analysis after being stained by Trypan blue for the
measurement of cell viability (n = 3).
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